NielsenMOwmanCh. Adrenergic innervation of pial arteries related to the circle of Willis in the cat. Brain Res1967;6:773–6.
2.
FalckBNielsenKCOwmanCh. Adrenergic innervation of the pial circulation. In: IngvarDHLassenNASiesjöBKSkinhøjE ed. Cerebral blood flow and cerebrospinal fluid. Scand J Clin Lab Invest1968;Suppl 102:96–8.
3.
OwmanChEdvinssonL ed. Neurogenic control of the brain circulation. Oxford: Pergamon Press, 1977.
4.
HeistadDDMarcusML ed. Cerebral blood flow. Effects of nerves and neurotransmitters. New York: Elsevier/North Holland, 1982.
5.
MacKenzieETSeylazJBèsA ed. Neurotransmitters and the cerebral circulation. New York: Raven Press, 1984.
6.
OwmanChHardeboJE ed. Neural regulation of brain circulation. Amsterdam: Elsevier, 1986.
7.
OwmanChEdvinssonL. Histochemical and pharmacological approach to the investigation of neurotransmitters, with particular regard to the cerebrovascular bed. In: OwmanChEdvinssonL ed. Neurogenic control of the brain circultion. Oxford: Pergamon Press, 1977:15–38.
8.
LjungB. Physiological patterns of neuroeffector control mechanisms. In: BevanJABurnstockGJohanssonBMaxwellRANedergaardCA ed. Vascular neuroeffector mechanisms. Basel: Karger, 1976:143–55.
9.
EdvinssonLOwmanChSjöbergN-O. Autonomic nerves, mast cells, and amine receptors in human brain vessels. A histochemical and pharmacological study. Brain Res1976;115:377–93.
10.
EdvinssonLOwmanCh. Sympathetic innervation and adrenergic receptors in intraparenchymal cerebral arterioles of baboon. Acta Physiol Scand1977;Suppl 452:57–9.
11.
SercombeRAubineauPEdvinssonLGrivasCMamoHOwmanChPinardESeylazJ. CBF changes by sympathetic nerve stimulation and denervation: correlation with the degree of sympathetic innervation of cerebral arterioles. In: HarperAMJennettWBMillerJDRowanJO ed. Blood flow and metabolism in the brain. Edinburgh: Churchill Livingstone, 1975:2.25–2.29.
12.
SercombeRAubineauPEdvinssonLMamoHOwmanChPinardESeylazJ. Neurogenic influence on local cerebral blood flow. Effect of catecholamines or sympathetic stimulation as correlated with the sympathetic innervation. Neurology1975;25:954–63.
13.
EdvinssonLLacombePOwmanCh.Reynier-RebuffelA-MSeylazJ. Quantitative changes in regional cerebral blood flow of rats induced by alpha- or beta-adrenergic stimulants. Acta Physiol Scand1979;107:289–96.
14.
EdvinssonLOwmanChRosengrenEWestKA. Concentration of noradrenaline in pial vessels, choroid plexus, and iris during two weeks after sympathetic ganglionectomy or decentralization. Acta Physiol Scand1972;85:201–6.
15.
EdvinssonLMacKenzieET. Amine mechanisms in the cerebral circulation. Pharmacol Rev1977;28:275–348.
16.
EdvinssonLNielsenKCOwmanChWestKA. Sympathetic adrenergic influence on brain vessels as studied by changes in cerebral blood volume of mice. Eur Neurol1971/72;6:193–202.
17.
HardeboJEOwmanCh. Barrier mechanisms for neurotransmitter monoamines and their precursors at the blood-brain barrier interface. Ann Neurol1979;8:1–11.
18.
HardeboJEEdvinssonLMacKenzieETOwmanCh. Regional brain uptake of noradrenaline following mechanical or osmotic opening of the blood-brain barrier. Acta Physiol Scand1977;191:342–50.
19.
EdvinssonLHardeboJEMackenzieETOwmanCh. Effects of exogenous noradrenaline on local cerebral blood flow after osmotic opening of the blood-brain barrier in the rat. J Physiol (Lond)1978;274:149–56.
20.
HartmanBKZideDUdenfriendS. The use of dopamine-β-hydroxylase as a marker for the central noradrenergic system in the rat brain. Proc Natl Acad Sci (USA)1972;69:2722–26.
21.
EdvinssonLLindvallMNielsenKCOwmanCh. Are brain vessels innervated also by central (non-sympathetic) adrenergic neurones?Brain Res1973;63:496–9.
22.
LindvallMCervós-NavarroJEdvinssonLOwmanChSteneviU. Non-sympathetic perivascular nerves in the brain: origin and mode of innervation studied by fluorescence and electron microscopy combined with stereotaxic lesions and sympathectomy. In: HarperAMJennettWBMillerJDRowanJO ed. Blood flow and metabolism in the brain. Edinburgh: Churchill Livingstone, 1975:1.7–1.9.
23.
NielsenKCOwmanChSporrongB. Ultrastructure of the autonomic innervation apparatus in the main pial arteries of rats and cats. Brain Res1971;27:25–32.
24.
RennelsMLNelsonE. Capillary innervation in the mammalian central nervous system: an electron microscopic demonstration. Am J Anat1975;144:233–41.
25.
RaichleMEGrubbRLJrEichlingJO. Neural and hormonal regulation of brain water permeability. In: OwmanChEdvinssonL ed. Neurogenic control of the brain circulation. Oxford: Pergamon Press, 1977:465–70.
26.
McCullochJSavakiHEAngersonW. Regional water permeability in the CNS of conscious rats: effects of hypercapnia and locus coeruleus lesions. In: HeistadDDMarcusML ed. Cerebral blood flow: Effects of nerves and neurotransmitters. New York: Elsevier/North-Holland, 1982:509–16.
27.
OwmanChEdvinssonLHardeboJEGröschel-StewartUUnsickerKWallesB. Immunohistochemical demonstration of actin and myosin in brain capillaries. Acta Neurol Scand1977;56, Suppl 64:384–5.
28.
EdvinssonLNielsenKCOwmanChSporrongB. Cholinergic mechanisms in pial vessels. Histochemistry, electron microscopy and pharmacology. Z Zellforsch1972;134:311–25.
29.
VerityMA. Morphological studies of the vascular neuroeffector apparatus. In: BevanJAFurchgottJAMaxwellRASomlyoAP ed. Physiology and pharmacology of vascular neuroeffector systems. Basel: Karger, 1971:2–12.
30.
EdvinssonLFalckBOwmanCh. Possibilities for a cholinergic action on smooth musculature and sympathetic axons in brain vessels mediated by muscarinic and nicotinic receptors. J Pharmacol Exp Ther1977;200:117–26.
31.
FurchgottRFZawadzkiJVCherryPD. Role of endothelium in the vasodilator response to acetylcholine. In: VanhouttePMLeusenI ed. Vasodilatation. New York: Raven Press, 1981:49–66.
32.
BevanJABugaGMSnowdenASaidSI. Is the neurovasodilator mechanism to cerebral and extracerebral arteries the same? In: HeistadDDMarcusML ed. Cerebral blood flow. Effects of nerves and neurotransmitters. New York: Elsevier/North-Holland, 1982:421–30.
33.
DuckiesSP. Acetylcholine and vasoactive intestinal polypeptide: cerebrovascular neurotransmitters. In: HeistadDDMarcusML ed. Cerebral blood flow: Effects of nerves and neurotransmitters, New York: Elsevier/North-Holland, 1982:441–6.
34.
MacKenzieETStewartMYoungARHarperAM. Cerebrovascular actions of serotonin. Adv Neurol1978;20:77–83.
35.
EdvinssonLHardeboJEOwmanCh. Pharmacological analysis of 5-hydroxytryptamine receptors in isolated intracranial and extracranial vessels of cat and man. Circ Res1978;42:143–151.
36.
ChangJ-YOwmanCh. Immunohistochemical and pharmacological studies on serotonergic nerves and receptors in brain vessels. In: Owman Ch, Lindvall-Axelsson M eds Cerebrovascular nerves and effects of amine transmitters and peptides on the brain circulation. Acta Physiol Scand1986;127,Suppl 552:49–53.
37.
SteinbuschHWMVerhofstadAAJJoostenHWJ. Localization of serotonin in the central nervous system by immunohistochemistry: description of a specific and sensitive technique and some applications. Neuroscience1978;3:811–19.
38.
GriffithSGLincolnJBurnstockG. Serotonin as a neurotransmitter in cerebral arteries. Brain Res1982;247:388–92.
39.
EdvinssonLDegueurceADuvergerDMacKenzieETScattonBUddmanR. Coupling between cerebral blood flow and metabolism: a role for serotonin? In: MacKenzieETSeylazJBèsA ed. Neurotransmitters and cerebral circulation. New York: Raven Press, 1984:121–36.
40.
GriffithSGBurnstockG. Immunohistochemical demonstration of serotonin in nerves supplying human cerebral and mesenteric blood-vessels. Some speculations about their involvement in vascular disorders. Lancet1983;8324:561–2.
41.
HokfeltTVincentSDalsgaadC-JSkirbollLJohanssonOSchultzbergMLundbergJMRosellSPernowBJancsoG. Distribution of substance P in brain and periphery and its possible role as a co-transmitter. In: LawrensonG ed Substance P in the nervous system. Ciba Foundation Symposium 91. London: Pitman, 1982:84–106.
42.
PelletierGSteinbuschHWMVerhofstadAAJ. Immunoreactive substance P and serotonin present in the same dense-core vesicles. Nature1981;293:71–2.
43.
EdvinssonLOwmanCh. A pharmacological comparison of histamine receptors in isolated extracranial and intracranial arteries in vitro. Neurology1975;25:271–6.
44.
WahlMKuschinskyW. The dilating effect of histamine on pial arteries of cats and its mediation by H2 receptors. Circ Res1979;44:161–5.
45.
GrossPM. Histamine H1 and H2-receptors are differentially and spatially distributed in cerebral vessels. J Cereb Blood Flow Metab1981;1:441–6.
46.
EdvinssonLCervós-NavarroJ. Larsson L-I, Owman Ch, Rönnberg A-L. Regional distribution of mast cells containing histamine, dopamine or 5-hydroxytryptamine in the mammalian brain. Neurology1977;27:878–83.
47.
von EulerUSGaddumJH. An unidentified depressor substance in certain tissue extracts. J Physiol (Lond)1931;72:74–87.
48.
PernowB. Studies on substance P. Purification, occurrence and biological actions. Acta Physiol Scand1953;105:1–90.
49.
ChangMMLeemanSENiallHH. Amino-acid sequence of substance P. Nature (New Biol)1971;232:86–7.
50.
LeemanSEMrozEASubstanceP. Life Sci1974;15:2033–44.
51.
LembeckFGamseR. Substance P in peripheral sensory processes. In: LawrensonG ed Substance P in the nervous system. Ciba Foundation Symposium 91. London: Pitman, 1982:35–54.
52.
OtsukaMKonishiSYanagisawaMTsunooAAkagiH. Role of substance P as a sensory transmitter in spinal cord and sympathetic ganglia. In: LawrensonG ed Substance P in the nervous system. Ciba Foundation Symposium 91. London: Pitman, 1982:13–34.
53.
UddmanREdvinssonLOwmanChSundlerF. Perivascular substance P: occurrence and distribution in mammalian pial vessels. J Cereb Blood Flow Metab1981;1:237–42.
54.
EdvinssonLMcCullochJUddmanR. Substance P: immunohistochemical localization and effect upon cat pial arteries in vitro and in situ. J Physiol (Lond)1981;318:251–58.
55.
EdvinssonLMcCullochJRosellSUddmanR. Antagonism by (D-Pro2, D-Trp7,9)-substance P of the cerebrovascular dilatation induced by substance P. Acta Physiol Scand1982;116:411–16.
56.
DuckiesSBuckS. Substance P in the cerebral vasculature: depletion by capsaicin suggests a sensory role. Brain Res1982;245:171–74.
57.
Liu-ChenLMaybergMMoskowitzM. Immunohistochemical evidence for a substance P-containing trigeminovascular pathway to pial arteries in cats. Brain Res1983;268:162–55.
58.
MaybergMLangerRZervosNMoskowitzM. Perivascular meningeal projections from cat trigeminal ganglia: possible pathway for vascular headaches in man. Science1981;213:228–30.
59.
HardeboJE. The involvement of trigeminal substance P neurons in cluster headache. An hypothesis. Headache1984;24:294–304.
60.
MoskowitzMA. The neurobiology of vascular head pain. Ann Neurol1984;16:157–68.
61.
ÖHägermarkHökfeltTPernowB. Flare and itch induced by substance P in human skin. J Invest Derm1978;71:233–35.
62.
LembeckFHolzerP. Substance P as a mediator of antidromic vasodilatation and neurogenic plasma extravasation. Naunyn-Schmiedebergs Arch Exp Path Pharmakol1979;310:175–83.
63.
SkofitschGSavittJMJacobowitzDM. Suggestive evidence for a functional unit between mast cells and substance P in fibres in the rat diaphragm and mesentery. Histochemistry1985;82:5–8.
64.
RosellSOlgartLGazeliusBPanopoulosPFolkersKHörigJ. Inhibition of antidromic and substance P-induced vasodilatation by a substance P antagonist. Acta Physiol Scand1981;111:381–82.
65.
AmaraSGJonasVRosenfeldMGOngLSEvansRM. Alternative RNA-processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature1982;298:240–44.
66.
LundbergJMFranco-CerecedaAHuaXHökfeltTFischerJ A. Co-existence of substance P and calcitonin gene-related peptide-like immunoreactivities in sensory nerves in relation to cardiovascular and bronchoconstrictor effects of capsaicin. Eur J Pharmacol1985;108:315–19.
67.
RosenfeldMGMermodJJAmaraSGSwansonLWSawchenkoPERivierJValeWWEvansRM. Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature1983;304:129–35.
68.
GibsonSJPolakJMBloomSRSabateIMMulderryPMGhatelMAMcGregorGPMorrisonJFBKellyJSEvansRMRosenfeldMG. Calcitonin gene-related peptide immunoreactivity in the spinal cord of man and eight other species. J Neurosci1984;4:3101–11.
69.
Wiesenfeld-HallinAHökfeltTLundbergJMForssmannWGReineckeMTschoppFAFischerJA. Immunoreactive calcitonin gene-related peptide and substance P coexist in sensory neurones to the spinal cord and interact in spinal behavioural responses of the rat. Neurosci Lett1984;52:199–204.
70.
HankoJHardeboJEKåhrströmJOwmanChSundlerF. Calcitonin gene-related peptide is present in mammalian cerebrovascular nerve fibres and dilated pial and peripheral arteries. Neurosci Lett1985;57:91–5.
71.
HankoJHardeboJEKåhrströmJOwmanChSundlerF. Existence and coexistence of calcitonin gene-related peptide (CGRP) and substance P in cerebrovascular nerves and trigeminal ganglion cells. In: Owman Ch, Lindvall-Axelsson eds Cerebrovascular nerves and effects of amine transmitters and peptides on the brain circulation. Acta Physiol Scand1986;127Suppl 552:29–32.
72.
BrainSDWilliamsTHTippinsJRMorrisHRMacIntyreI. Calcitonin gene-related peptide is a potent vasodilator. Nature1985;313:54–6.
73.
Le GrevésPNybergFTereniusLHökfeltT. Calcitonin gene-related peptide is a potent inhibitor of substance P degradation. Eur J Pharmacol1985;115:309–11.
74.
SaidSIMuttV. Polypeptide with broad biological activity. Isolation from small intestine. Science1970;169:1217–18.
75.
MuttVSaidSI. Structure of porcine vasoactive intestinal octacosa peptide. The amino-acid sequence. Use of kallikrein in its determination. Eur J Biochem1974;42:581–9.
76.
BodanskyMKlausnerYXLinCYMuttVSaidSI. Synthesis of the vasoactive intestinal peptide (VIP). J Am Chem Soc1974;96:4973–8.
77.
CarlquistMMuttVJörnvallH. Isolation and characterization of bovine vasoactive intestinal polypeptide (VIP). FEBS Lett1979;108:457–60.
78.
CarlquistMJörnvallHTatemotoKMuttV. A porcine brain polypeptide is identical to the vasoactive intestinal polypeptide. Gastroenterology1982;83:245–9.
79.
SaidSIMuttV. Potent peripheral and splanchnic vasodilator peptide from normal gut. Nature1970;225:863–5.
80.
SaidSIMuttV. Isolation from porcine-intestinal wall of a vasoactive octacosapeptide related to secretin and to glucagon. Eur J Biochem1972;28:199–215.
81.
LarssonL-IEdvinssonLFahrenkrugJHåkansonROwmanChSchaffalitzky de MuckadellOBSundlerF. Immunohistochemical localization of a vasodilatory polypeptide (VIP) in cerebrovascular nerves. Brain Res1976;113:400–4.
82.
EdvinssonLFahrenkrugJHankoJOwmanChSundlerFUddmanR. VIP (vasoactive intestinal polypeptide)-containing nerves of intracranial arteries in mammals. Cell Tissue Res1980;208:135–42.
83.
OwmanChAnderssonJHankoJHardeboJE. Neurotransmitter amines and peptides in the cerebrovascular bed. In: MacKenzieETSeylazJBèsA ed. Neurotransmitters and the cerebral circulation. New York: Raven Press, 1984;11–38.
84.
GibbonsILBraydenJEBevanJA. Perivascular nerves with immunoreactivity to vascoactive intestinal polypeptide in cephalic arteries of the cat: distribution, possible origins and functional implications. Neuroscience1984;13:1327–46.
85.
DuckiesSPSaidSI. Vasoactive intestinal peptide as a neurotransmitter in the cerebral circulation. Eur J Pharmacol1982;78:371–4.
86.
EdvinssonLFahrenkrugJHankoJMcCullochJOwmanCh. Vasoactive intestinal polypeptide: distribution and effects on cerebral blood flow and metabolism. In: Cervos-NavarroJFritschkaE ed. Cerebral microcirculation and metabolism. New York: Raven Press, 1981:147–55.
87.
WeiEPKontosHASaidSI. Mechanism of action of vasoactive intestinal polypeptide on cerebral arterioles. Am J Physiol1980;239:765–8.
88.
HuangMRorstadOP. Effects of vasoactive intestinal polypeptide, monoamines, prostaglandins, and 2-chloroadenosine on adenylate cyclase in rat cerebral microvessels. J Neurochem1983;40:719–26.
89.
LindvallMGustafsonAHednerPOwmanCh. Stimulation of cyclic adenosine 3,5-monophosphate formation in rabbit choroid plexus by β-receptor agonists and vasoactive intestinal polypeptide. Neurosci Lett1985;54:153–7.
90.
LundbergJMHökfeltTSchultzbergMUvnäs-WallensteinKKöhlerCSaidSI. Occurence of vasoactive intestinal polypeptide (VIP)-like immunoreactivity in certain cholinergic neurones of the cat: evidence from combined immunohistochemistry and acetylcholinesterase staining. Neuroscience1979;4:1539–59.
91.
JohanssonOLundbergJM. Ultrastructural localization of VIP-like immunoreactivity in large dense-core vesicles of “cholinergic type” nerve terminals in cat exocrine glands. Neuroscience1981;5:847–62.
92.
LundbergJMFriedGFahrenkrugJHolmstedtBHökfeltTLagercrantzHLundgrenGÄnggårdA. Subcellular fractionation of cat submandibular gland: comparative studies on the distribution of acetylcholine and vasoactive intestinal polypeptide (VIP). Neuroscience1981;6:1001–10.
93.
TatemotoKCarlquistMMuttV. Neuropeptide Y—a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature1982;296:659–60.
94.
LundbergJMHökfeltTÄnggårdAKimmelJGoldsteinMMarkeyK. Co-existence of an avian pancreatic polypeptide (APP) immunoreactive substance and catecholamines in some peripheral and central neurons. Acta Physiol Scand1980;110:107–9.
95.
HuntSPEmsonPCGilbertRGoldsteinMKimmelJR. Presence of avian pancreatic polypeptide-like immunoreactivity in catecholamine and methionine-enkephalin-containing neurons within the central nervous system. Neurosci Lett1982;21:125–30.
96.
UddmanREdvinssonLHåkansonROwmanChSundlerF. Immunohistochemical demonstration of APP (avian pancreatic polypeptide)-immunoreactive nerve fibres around central blood vessels. Brain Res Bull1982;9:715–8.
97.
GuJAdrianTETatemotoKPollakJMAllenJMBloomSR. Neuropeptide tyrosine (NPY)—a major cardiac neuropeptide. Lancet1983;1:1008–10.
98.
LundbergJMTereniusLHökfeltTGoldsteinM. High levels of neuropeptide Y in peripheral noradrenergic neurons in various mammals including man. Neurosci Lett1983;42:169–72.
99.
UddmanREkbladEEdvinssonLHåkansonRSundlerF. Neuropeptide Y-like immunoreactivity in perivascular nerve fibres of the guinea-pig. Regulatory Peptides1985;10:243–57.
100.
EdvinssonLEmsonPMcCullochJTatemotoKUddmanR. Neuropeptide Y: cerebrovascular innervation and vasomotor effects in the cat. Neurosci Lett1983;43:79–84.
101.
EdvinssonLEmsonPMcCullochJTatemotoKUddmanR. Neuropeptide Y: immunocytochemical localization to and effect upon feline pial arteries and veins in vitro and in situ. Acta Physiol Scand1984;122:155–63.
102.
EkbladEEdvinssonLWahlestedtCUddmanR.HåkansonRSundlerF. Neuropeptide Y coexists and co-operates with noradrenaline in perivascular nerve fibres. Regulatory Peptides1984;8:255–35.
103.
HardeboJEAnderssonJHankoJOwmanCh. Purinergic and peptidergic vasomotor mechanisms in the brain. In: VanhouttePMVatnerSF ed. Vasodilator mechanisms. Basel: Karger, 1984:128–37.
104.
LundbergJMTereniusLHökfeltTMartlingCRTatemotoKMuttVPollakJBloomSGoldsteinM. Neuropeptide Y (NPY)-like immunoreactivity in the peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol Scand1982;116:477–80.
105.
StjernquistMOwmanChSjöbergN-OSundlerF. Co-existence and cooperation between neuropeptide Y and norepinephrine in nerve fibres of guinea-pig vas deferens and seminal vesicle. Biol Reprod1986; in press.
106.
HankoJTörnebrandtKHardeboJEKährströmJNobinAOwmanCh. Neuropeptide Y induces and modulates vasoconstriction in intracranial and peripheral vessels of animals and man. J Auton Pharmacol1986; in press.
107.
EdvinssonLEkbladEHåkansonRWahlestedtC. Neuropeptide Y potentiates the effect of various vasoconstrictor agents on rabbit blood vessels. Br J Pharmacol1984;893:519–25.
108.
LundbergJHuaX-YCerecedaA Franco. Effects of neuropeptide Y (NPY) on mechanical activity and neurotransmission in the heart, vas deferens and urinary bladder of guinea-pig. Acta Physiol Scand1984;121:325–32.
109.
HardeboJEHankoJKåhrströmJOwmanCh. Electrical field stimulation in cerebral and peripheral arteries: a critical evaluation of the contractile response. J Auton Pharmacol1986; in press.
110.
McDonaldTJNilssonGVagneMGhateiMBloomSRMuttV. A gastrin releasing peptide from non-antral gastric tissue. Gut1978;19:767–74.
111.
McDonaldTJJörnvallHNilssonGVagneMBloomSRMuttV. Characterization of a gastrin releasing peptide from porcine non-antral gastric tissue. Biochem. Biophys Res Commun1979;90:227–33.
112.
ErspamerVMelchiorriPErspamerG FalconieriNegriL. Polypeptides of the amphibian skin active on the gut and their mammalian counterparts. In: GrossmanMESperanzaVBassoNLazocheE ed. Gastrointestinal hormones and pathology of the digestive system. New York: Plenum Press, 1978:61–4.
113.
StjernquistMHåkansonRLeanderSOwmanChSundlerFUddmanR. Immunohistochemical localization of substance P, vasoactive intestinal polypeptide, and gastrin-releasing peptide in vas deferens and seminal vesicle, and the effect of these and eight other neuropeptides on resting tension and neurally evoked contractile activity. Regulatory Peptides1983;7:67–86.
114.
StjermquistMEkbladEOwmanChSundlerF. Neuronal localization and motor effects on gastrin-releasing peptide (GRP) in rat uterus. Regulatory Peptides1985;13:197–206.
LeanderSEkmanRUddmanRSundlerFHåkansonR. Neuronal cholecystokinin, gastrin-releasing peptide, neurotensin and -endorphin in guinea-pig intestine. Distribution and possible motor functions. Cell Tissue Res1984;235:521–31.
117.
HendrySHCJonesEGBeinfieldMC. Cholecystokinin-immunoreactive neurons in rat and monkey cerebral cortex makes symmetric synapses and have intimate associations with blood vessels. Proc Natl Acad Sci USA1983;80:2400–4.
118.
LundbergJMHokfeltT. Coexistence of peptides and classical neurotransmitters. Trends Neurosci1983;6:325–33.
119.
HardeboJEEdvinssonLEmsonPCOwmanCh. Isolated brain microvessels: enzymes related to adrenergic and cholinergic functions. In: OwmanChEdvinssonL ed. Neurogenic control of the brain circulation. Oxford: Pergamon Press, 1977:105–113.